Article
Subscribe
In this third session, the physicians discuss how they communicate to their patients the increased risk of stroke that may be associated with dosing of anti-VEGF agents.
Participants include:
Return to Retina Roundtable Podcast Series
Return to Ophthalmology Times Radio